| Neutrophil Extracellular Traps in Arterial and Venous Thrombosis |
40 |
| Bleeding and Thrombotic Complications in the Use of Extracorporeal Membrane Oxygenation |
22 |
| Next-Generation Sequencing and Emerging Technologies |
21 |
| Pulmonary Thrombosis: A Clinical Pathological Entity Distinct from Pulmonary Embolism? |
17 |
| Current and Emerging Direct Oral Anticoagulants: State-of-the-Art |
17 |
| The Safety and Efficacy of Novel Agents Targeting Factors XI and XII in Early Phase Human Trials |
14 |
| Venous and Arterial Thromboses: Two Sides of the Same Coin? |
11 |
| Use of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Malignancy: Clinical Practice Experience in a Single Institution and Literature Review |
10 |
| Fibrin and Fibrinolysis in Cancer |
10 |
| Clinical Application of Thromboelastography/Thromboelastometry (TEG/TEM) in the Neonatal Population: A Narrative Review |
10 |
| Inhibition of Factors XI and XII for Prevention of Thrombosis Induced by Artificial Surfaces |
10 |
| Nonvitamin K Antagonist Oral Anticoagulants Use in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves/Prior Surgical Valve Repair: A Multicenter Clinical Practice Experience |
9 |
| Prevalence and Thrombotic Risk Assessment of Anti-beta(2) Glycoprotein I Domain I Antibodies: A Systematic Review |
9 |
| Gene Therapy: Paving New Roads in the Treatment of Hemophilia |
9 |
| Toward Flow Cytometry Based Platelet Function Diagnostics |
8 |
| Intracranial Hemorrhage and Early Mortality in Patients Receiving Extracorporeal Membrane Oxygenation for Severe Respiratory Failure |
8 |
| Vitamin K-Dependent Protein S: Beyond the Protein C Pathway |
8 |
| Hemostasis at Extremes of Body Weight |
8 |
| Detecting Anti-IIa and Anti-Xa Direct Oral Anticoagulant (DOAC) Agents in Urine using a DOAC Dipstick |
8 |
| Risk of Venous Thrombosis in Antithrombin Deficiency: A Systematic Review and Bayesian Meta-analysis |
8 |
| The Epidemiology of Cancer-Associated Venous Thromboembolism: An Update |
8 |
| Role of Tissue Factor in Tumor Progression and Cancer-Associated Thrombosis |
8 |
| Preanalytical Variables in Coagulation Testing: Setting the Stage for Accurate Results |
8 |
| Antithrombotic Treatment after Transcatheter Heart Valves Implant |
8 |
| Atrial Fibrillation and Malignancy: The Clinical Performance of Non-Vitamin K Oral AnticoagulantsA Systematic Review |
8 |
| Inherited Thrombophilia and Pregnancy Complications: Should We Test? |
7 |
| How to Optimize Activated Partial Thromboplastin Time (APTT) Testing: Solutions to Establishing and Verifying Normal Reference Intervals and Assessing APTT Reagents for Sensitivity to Heparin, Lupus Anticoagulant, and Clotting Factors |
7 |
| Cardiac Manifestations of Antiphospholipid Syndrome: Clinical Presentation, Role of Cardiac Imaging, and Treatment Strategies |
7 |
| The Elusive Diagnosis of Disseminated Intravascular Coagulation: Does a Diagnosis of DIC Exist Anymore? |
7 |
| Molecular Diagnosis of Inherited Coagulation and Bleeding Disorders |
7 |
| Pathogenesis and Management of Thrombotic Disease in Myeloproliferative Neoplasms |
7 |
| Cancer-Associated Thrombosis: A Two-Way Street |
7 |
| To What Extent Are the Terminal Stages of Sepsis, Septic Shock, Systemic Inflammatory Response Syndrome, and Multiple Organ Dysfunction Syndrome Actually Driven by a Prion/Amyloid Form of Fibrin? |
7 |
| Involvement of Platelets in Cancers |
6 |
| Inhibitors in Hemophilia B |
6 |
| The Tissue Factor Pathway and Wound Healing |
6 |
| Sudden Cardiac and Noncardiac Death in Sports: Epidemiology, Causes, Pathogenesis, and Prevention |
6 |
| Toxins Are an Excellent Source of Therapeutic Agents against Cardiovascular Diseases |
6 |
| Use of Viscoelastography in Malignancy-Associated Coagulopathy and Thrombosis: A Review |
6 |
| Tissue Factor and Cancer: Regulation, Tumor Growth, and Metastasis |
6 |
| The Lupus Anticoagulant Paradox |
6 |
| Direct Oral Anticoagulants for Thromboprophylaxis in Patients with Antiphospholipid Syndrome |
6 |
| Pathological Clotting and Deep Vein Thrombosis in Patients with HIV |
6 |
| Analytical Assessment of the New Roche Cobas t 711 Fully Automated Coagulation Analyzer |
5 |
| New Anticoagulant Agents: Incidence of Adverse Drug Reactions and New Signals Thereof |
5 |
| Inhibitor Formation in Congenital Hemophilia A: an Immunological Perspective |
5 |
| Thromboinflammatory Functions of Platelets in Ischemia-Reperfusion Injury and Its Dysregulation in Diabetes |
5 |
| Platelet CLEC-2: Roles Beyond Hemostasis |
5 |
| Emerging Roles for von Willebrand Factor in Cancer Cell Biology |
5 |
| Recent Advances in Mainstream Hemostasis Diagnostics and Coagulation Testing |
5 |
